Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Research progress on the relationship between fibroblast growth factor 23 and chronic kidney disease
Vol 4, Issue 1, 2023
VIEWS - 1579 (Abstract)
Download PDF
Abstract
Chronic kidney disease(CKD)is now a global public health problem. In chronic kidney disease(CKD)patients，almost all have complications such as calcium and phosphorus metabolism disorders，hyperparathyroidism，cardiovascular disease，anemia，and inflammation，which seriously affect the progress and prognosis of CKD. Fibroblast growth factor 23(FGF23) is a bone-derived hormone that regulates the metabolism of phosphate and vitamin D. In the past，FGF23 was generally considered to play only an important role in the regulation of calcium and phosphorus metabolism. In recent years FGF23has been found to be associated with the occurrence or progression of various CKD complications. This opens up new horizons for studying the role of FGF23 in the course of chronic kidney disease. FGF23 is expected to become a new therapeutic target in the future，improving the prognosis of patients with CKD. This article will review the biological characteristics of FGF23 and its role in the progression of CKD. And briefly discuss its potential future role in chronic kidney disease.
Keywords
References
1. LIN B，SHAO L，LUO Q，et al. Prevalence of chronic kidney disease and its association with metabolic diseases:a cross-sectional survey in Zhejiang province，Eastern China[J]. BMC nephrology，2014，2014:15361540.
2. LARSSON T，NISBETH U，LJUNGGREN O，et al. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease，but does not change in response to variation in phosphate in- take in healthy volunteers[J]. Kidney Int，2003，64 (6):2272-2279.
3. Cao Juan Fibroblast growth factor 23 and the progress of chronic kidney disease [J] Chinese Journal of integrated traditional Chinese and Western medicine nephropathy, 2015 (5): 96-98
4. Li Yingxia, Cheng Hong, Wang Xiaoqin Research progress of FGF23 in chronic kidney disease [J] Chinese Journal of integrated traditional Chinese and Western medicine nephropathy, 2018, 19 (8): 741-743
5. STUBBS J，LIU S，QUARLES L D. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease[J]. Semin Dial，2007，20(4):302-308.
6. YAMASHITA T，YOSHIOKA M，ITOH N. Identification of a novel fibroblast growth factor，FGF-23，preferentially expressed in the ventrolateral thalamic nucleus of thebrain[J]. Biochemicalandbiophysicalresearchcommunications，2000，277(2):494-498.
7. WHITE K E，JONSSON K B，CARN G，et al. The autosomal dominant hypophosphatemic rickets(ADHR)gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting[J]. The Journal of clinical endocrinology and metabolism，2001，86(2):497-500.
8. KUROSU H，OGAWA Y，MIYOSHI M，et al. Regulation of fibroblast growth factor-23 signaling by klotho[J]. The Journal of biological chemistry，2006，281 (10):6120-6123.
9. YU X，IBRAHIMI O A，GOETZ R，et al. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23[J]. Endocrinology，2005， 146(11):4647-4656.
10. LIU S，VIERTHALER L，TANG W，et al. FGFR3 and FGFR4 do not mediate renal effects of FGF23[J]. J Am Soc Nephrol，2008，19(12):2342-2350.
11. WU A L，FENG B，CHEN M Z，et al. Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia[J]. PLoS One，2013，8(2): e57322-e57326.
12. KURO-O M，MATSUMURA Y，AIZAWA H，et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing[J]. Nature， 1997， 390(6655): 45-51.
13. ITO S，KINOSHITA S，SHIRAISHI N，et al. Molecular cloning and expression analyses of mouse betaklotho， which encodes a novel Klotho family protein[J]. Mechanisms of development，2000，98(1-2):115-119.
14. ITO S，FUJIMORI T，HAYASHIZAKI Y，et al. Identification of a novel mouse membrane-bound family 1 glycosidase-like protein，which carries an atypical active site structure[J]. Biochimica et biophysica acta，2002，1576(3):341-345.
15. XU Y，SUN Z. Molecular basis of Klotho:from gene to function in aging[J]. Endocrine reviews，2015，36 (2):174-193.
16. CHEN G，LIU Y，GOETZ R，et al. alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling[J]. Nature，2018，553(7689):461-466.
17. HAN X，QUARLES L D. Multiple faces of fibroblast growth factor-23[J]. Curr Opin Nephrol Hypertens， 2016，25(4):333-342.
18. URAKAWA I，YAMAZAKI Y，SHIMADA T，et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23[J]. Nature，2006，444(7120): 770-774.
19. LEIFHEIT-NESTLER M，HAFFNER D. Paracrine Effects of FGF23 on the Heart[J]. Frontiers in endocrinology，2018，2018:9278-9282.
20. QUARLES L D. Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism[J]. Nature reviews Endocrinology，2012，8(5):276-286.
21. ERBEN R G，ANDRUKHOVA O. FGF23-Klotho signaling axis in the kidney[J]. Bone，2017，100:62-68.
22. DELIOT N， HERNANDO N， ZHORST-LIU，et al. Parathyroid hormone treatment induces dissociation of type IIa Na+-P(i)cotransporter-Na+/H+ exchanger regulatory factor-1 complexes[J]. American journal of physiology Cell physiology， 2005， 289(1): C159C167.
23. LARSSON T， MARSELL R， SCHIPANI E， et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I)collagen promoter exhibit growth retardation，osteomalacia，and disturbed phosphate homeostasis[J]. Endocrinology，2004，145 (7):3087-3094.
24. ANDRUKHOVA O， ZEITZ U， GOETZ R， et al. FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway[J]. Bone，2012，51(3):621-628.
25. ANDRUKHOVA O， SMORODCHENKO A， EGERBACHER M，et al. FGF23 promotes renal calcium reabsorption through the TRPV5 channel[J]. The EMBO journal，2014，33(3):229-246.
26. KHANAL R，NEMERE I. Membrane receptors for vitamin D metabolites[J]. Critical reviews in eukaryotic gene expression，2007，17(1):31-47.
27. SHIMADA T，HASEGAWA H，YAMAZAKI Y，et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis[J]. Journal of bone and mineral research :the official journal of the American Society for Bone and Mineral Research，2004，19(3): 429-435.
28. KRAJISNIK T，BJORKLUND P，MARSELL R，et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells[J]. The Journal of endocrinology，2007，195(1):125-131.
29. MEIR T，DURLACHER K，PAN Z，et al. Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription[J]. Kidney Int，2014，86 (6):1106-1115.
30. ISAKOVA T，WAHL P，VARGAS G S，et al. Fibro- blast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease[J]. Kidney Int，2011，79(12):1370-1378.
31. OLAUSON H，VERVLOET M G，COZZOLINO M，et al. New insights into the FGF23-Klotho axis[J]. Seminars in nephrology，2014，34(6):586-597.
32. SAKAN H，NAKATANI K，ASAI O，et al. Reduced renal α- Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism[J]. PLoS One，2014，9(1):e86301-e86307.
33. ASAI O，NAKATANI K，TANAKA T，et al. Decreased renal alpha-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion[J]. Kidney Int，2012，81(6): 539-547.
34. KRAJISNIK T，OLAUSON H，MIRZA M A，et al. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients[J]. Kidney Int，2010，78(10):1024-1032.
35. DONATE-CORREA J， MARTIN-NUNEZ E， HERNANDEZ-CARBALLO C，et al. Fibroblast growth factor 23 expression in human calcified vascular tissues[J]. Aging，2019，11(18):7899-7913.
36. JIMBO R，KAWAKAMI-MORI F，MU S，et al. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency[J]. Kidney Int，2014，85(5):1103-1111.
37. SCIALLA J J，LAU W L，REILLY M P，et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification[J]. Kidney Int，2013，83 (6):1159-1168.
38. ZHU D，MACKENZIE N C，MILLAN J L，et al. A pro- tective role for FGF-23 in local defence against disrupt- ed arterial wall integrity? [J]. Molecular and cellular endocrinology，2013，372(1-2):1-11.
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Bingqing Liao, Xinwu Liu, Chengbo Zhao, Runxiu Wang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
.png)
Prof. Wei-Yen Hsu
National Chung Cheng University, Taiwan
